By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 114.88 |
Change Today | $ 0.12 |
% Change | 0.10 % |
52 Week High | $117.41 |
52 Week Low | $72.73 |
Volume | 1,588,759 |
Shares Issued | 1,246.00m |
Market Cap | $143,140m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 9 |
Neutral | 8 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
12:08 | 100 @ $114.88 |
12:08 | 100 @ $114.89 |
12:08 | 100 @ $114.89 |
12:08 | 143 @ $114.89 |
12:08 | 100 @ $114.90 |
You are here: research